首页> 外文期刊>journal of pharmaceutical innovation >The Reform of the Orphan Drug Assessment System in China
【24h】

The Reform of the Orphan Drug Assessment System in China

机译:

获取原文
获取原文并翻译 | 示例
           

摘要

This perspective article provides historical background and current considerations of the regulation of rare diseases and orphan drugs in China, presenting the ongoing reform of the orphan drug assessment system in the context of a maze of seemingly convoluted government agencies and regulatory policies that are unique to the fast developing China.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号